Omega-3s, lion's mane, phosphatidylserine, B vitamins, and vitamin D all have research behind them for cognitive health. Here is an honest look at what the evidence actually supports — and what it does not.
For educational purposes only — not medical advice. How we evaluate evidence →
Evidence-based strategies to protect and preserve cognitive function.
Also in this series
The Dementia Prevention Diet: What to Eat to Protect Your BrainExercise and Dementia Prevention: The Most Powerful Brain-Protective InterventionCreatine and Cognitive Health: What the Evidence Actually ShowsLiving with Dementia: Daily Management, Maintenance, and Quality of Life+1 more in this series
Reviewed by
Dr. A. Ferreira, MDGeneral practitioner with integrative medicine training. Reviewed for factual accuracy and safety. No supplement has been proven to prevent or treat dementia. Supplement interactions with medications are common — always consult your healthcare provider.
Last reviewed
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health decisions. Our editorial standards →
The global supplement market for brain health and memory is enormous — and largely driven by marketing rather than evidence. Most products sold for 'memory support' or 'cognitive enhancement' have little or no rigorous clinical evidence behind them. However, a handful of supplements have accumulated a meaningful body of research suggesting genuine benefit for cognitive aging, particularly in individuals with nutritional deficiencies or specific risk factors. This article separates the evidence-supported from the speculative — and explains why individual assessment matters more than any generic supplement stack.
Omega-3 Fatty Acids (EPA and DHA): The Strongest Evidence. DHA (docosahexaenoic acid) is a structural component of neuronal membranes — approximately 30% of the brain's grey matter is DHA. Low DHA levels are consistently associated with increased dementia risk in epidemiological studies. The evidence for supplementation is mixed but leans positive for specific populations: a 2022 Cochrane review found that omega-3 supplementation did not significantly improve cognitive function in cognitively healthy older adults, but several trials have shown benefit in individuals with mild cognitive impairment (MCI) or low baseline DHA levels. The MIDAS trial found that DHA supplementation (900 mg/day for 24 weeks) significantly improved learning and memory in adults with age-related cognitive decline. Recommended dose: 1–2 g combined EPA+DHA daily, ideally from fish oil or algae-based sources (the latter is suitable for vegetarians and avoids heavy metal concerns).
B Vitamins (B6, B9/Folate, B12): Homocysteine and Brain Atrophy. Elevated homocysteine is one of the most consistent biomarkers associated with accelerated brain atrophy and dementia risk. Homocysteine is regulated by B6, folate, and B12 — and deficiency in any of these raises homocysteine levels. The VITACOG trial (Oxford, 2010) found that B vitamin supplementation (B6, B12, folic acid) in older adults with MCI and elevated homocysteine reduced brain atrophy by 53% over 2 years compared to placebo — one of the most striking results in nutritional neuroscience. A 2017 follow-up found that the benefit was concentrated in those with high omega-3 levels, suggesting a synergistic effect. B12 deficiency is particularly common in adults over 60 (due to declining gastric acid production) and can cause cognitive symptoms that are fully reversible with supplementation. Testing homocysteine and B12 levels before supplementing is strongly recommended.
Vitamin D receptors are expressed throughout the brain, and vitamin D plays roles in neuroinflammation, amyloid clearance, and neuroprotection. Multiple large cohort studies have found that low vitamin D levels (below 25 nmol/L) are associated with a 2-fold increase in dementia risk. The VITAL-Cog trial (a sub-study of the large VITAL trial) found that vitamin D3 supplementation (2000 IU/day) was associated with significantly lower rates of cognitive decline in adults over 70. Optimal serum levels for brain protection appear to be 75–125 nmol/L (30–50 ng/mL). Given that over 40% of adults are deficient, testing and supplementing to optimal levels is one of the most straightforward interventions available.
Lion's Mane Mushroom (Hericium erinaceus): The Most Promising Nootropic. Lion's mane contains hericenones and erinacines — compounds that stimulate the production of nerve growth factor (NGF), a protein essential for the growth, maintenance, and survival of neurons. A 2009 Japanese RCT (Mori et al.) found that lion's mane supplementation (3g/day for 16 weeks) significantly improved cognitive function in adults with mild cognitive impairment compared to placebo — with scores declining back to baseline after supplementation stopped. A 2023 Australian RCT found that lion's mane (1.8g/day for 12 weeks) significantly improved processing speed and working memory in healthy adults aged 18–45. The evidence is preliminary but promising. Typical dose: 500–3000 mg/day of dried mushroom or standardised extract.
Phosphatidylserine (PS): The FDA-Qualified Claim. Phosphatidylserine is a phospholipid that is a major structural component of neuronal membranes, particularly in the hippocampus. It plays a role in cell-to-cell communication, glucose metabolism in the brain, and the activity of neurotransmitters including acetylcholine and dopamine. The FDA has granted a qualified health claim that PS 'may reduce the risk of dementia and cognitive dysfunction in the elderly' — one of the very few supplements to receive such recognition. Multiple RCTs have shown that PS supplementation (100–300 mg/day) improves memory, concentration, and cognitive function in older adults with age-associated memory impairment. The original research used bovine-derived PS; current supplements use soy-derived PS, which has somewhat weaker evidence but is generally considered equivalent.
Standard magnesium supplements (oxide, citrate, glycinate) have limited ability to cross the blood-brain barrier. Magnesium L-threonate was specifically developed to increase brain magnesium levels. A 2016 study in the Journal of Alzheimer's Disease found that magnesium L-threonate supplementation significantly improved cognitive function in older adults with cognitive impairment. Animal studies have shown it can reverse synaptic density loss and improve memory. The human evidence is still limited, but the mechanism is plausible and the safety profile is excellent. Dose: 1.5–2 g/day of magnesium L-threonate (providing approximately 140 mg elemental magnesium).
Ginkgo biloba: once widely promoted for memory, the large GEMS trial (3,069 participants, 6 years) found no significant effect on dementia incidence. Curcumin: promising in animal studies, but poor bioavailability limits human translation; results from RCTs are mixed. Resveratrol: interesting mechanistically (SIRT1 activation, amyloid clearance) but clinical trials have been disappointing. Acetyl-L-carnitine: some evidence for mild cognitive impairment, but effect sizes are small and inconsistent. CoQ10: important for mitochondrial function but no strong evidence for dementia prevention specifically.
The WHO 2026 Position on Supplements. The World Health Organization's updated 2026 recommendations do not support routinely taking vitamins B or E, omega-3 supplements, or multivitamins specifically to prevent cognitive decline in people without a diagnosed deficiency. This is an important counterweight to the supplement marketing that frequently runs ahead of the science. The practical recommendation: check for actual deficiencies before buying a cabinet full of supplements. A clinician can review medications, nutrition, and appropriate blood tests — vitamin B12, vitamin D, iron, and omega-3 index are the most relevant starting points. Supplements can interact with prescription drugs, and more is not necessarily better. The supplements with the strongest case are those correcting a documented deficiency, not those taken speculatively.
Supplement Evidence Summary: What the Research Actually Shows. Vitamin B12: important if deficient — correcting a deficiency may improve related cognitive symptoms, but it is not a proven Alzheimer's treatment in people with normal B12 levels. Vitamin D: correct a deficiency for general health; not established as a dementia treatment. Omega-3 fish oil: important nutrients, but supplements have not consistently improved cognition in established dementia — whole food sources (fatty fish) are preferable. Vitamin B complex: may be appropriate for a diagnosed deficiency or particular medical indication; not a proven general dementia therapy. Curcumin/turmeric: interesting laboratory and early clinical research, but insufficient evidence to recommend as a dementia treatment — bioavailability remains a major limitation. Creatine: research into brain and cognitive effects is ongoing and promising, particularly for energy metabolism; not yet an established dementia treatment. Lion's mane mushroom: early, limited human research; no convincing evidence that it treats dementia, though the mechanism (NGF stimulation) is biologically plausible. Ginkgo biloba: some studies suggest possible symptom benefits from specific standardised extracts, but evidence is inconsistent and the large GEMS trial found no effect on dementia incidence — it can interact with medications and increase bleeding risk. Vitamin E: some evidence suggests a particular high-dose regimen may slow functional decline in selected Alzheimer's patients, but it is not a cure and high doses increase bleeding risk — do not self-prescribe high doses.
Personalised plan
Get a personalised care and prevention plan tailored to your situation.
Seen a claim you want to verify?
The Claim Decoder grades the evidence behind any natural health claim — A to F, with sources.
Suggested from this article:
"Lion's mane mushroom stimulates nerve growth factor in humans"
Prompted by: Supplements for Brain Health: What the Evidence Says About Dementia Prevention
The MIND diet reduces Alzheimer's risk by up to 53% in adherent individuals. Here is what the evidence says about food, brain aging, and cognitive decline — and the practical eating pattern that protects the most.
Regular aerobic exercise reduces dementia risk by 30–40% in large cohort studies. A landmark twin study found leg-focused resistance training produced a 47% improvement in cognitive performance. It also grows the hippocampus, increases BDNF, and clears amyloid. Here is the evidence — and the minimum effective dose.
Creatine is not just for athletes. The brain uses creatine as an energy buffer, and supplementation has shown measurable cognitive benefits — particularly under stress, sleep deprivation, and in aging populations.
